MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202641073431 A) filed by Mr. Saravanan Manikandan; Ms. Heranmayee Barani; and Mr. Rakesh Bettadapura Manohara on June 12, 2026, for An Intelligent Crp Monitoring And Inflammatory Risk Assessment Device.
Inventors include Mr. Saravanan Manikandan; Ms. Heranmayee Barani; and Mr. Rakesh Bettadapura Manohara.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: ABSTRACT An Intelligent CRP Monitoring and Inflammatory Risk Assessment Device The present invention relates to an intelligent C-Reactive Protein (CRP) monitoring and inflammatory risk assessment device designed for real-time detection, analysis, and prediction of inflammatory conditions in patients. The device integrates a highly sensitive biosensor module capable of detecting CRP concentrations from biological samples such as blood, serum, plasma, or interstitial fluid with advanced artificial intelligence-based analytics for comprehensive inflammatory risk evaluation. The biosensor utilizes electrochemical, optical, or microfluidic sensing technology to generate accurate CRP measurements with minimal sample volume and rapid processing time. A microcontroller-based processing unit collects sensor data and transmits it to a cloud-connected platform through wireless communication technologies including Bluetooth, Wi-Fi, or cellular networks. The embedded intelligent algorithm analyzes CRP trends, patient history, demographic factors, vital signs, and associated biomarkers to assess inflammation severity and predict disease progression risks. The system generates personalized risk scores and provides healthcare professionals with actionable insights through a mobile application and web-based dashboard. Automated alert mechanisms notify users and caregivers when CRP levels exceed predefined thresholds or when abnormal inflammatory patterns are detected. The device supports continuous monitoring, remote healthcare management, and early intervention strategies for chronic inflammatory diseases, cardiovascular disorders, infections, autoimmune conditions, and post-surgical recovery. Machine learning models continuously improve prediction accuracy through adaptive learning from accumulated patient data. The invention reduces dependence on laboratory-based testing, enables point-of-care diagnostics, enhances clinical decision-making, and improves patient outcomes through timely detection and management of inflammatory conditions. The proposed intelligent CRP monitoring system represents a significant advancement in personalized healthcare, preventive medicine, and digital health technologies.
Disclaimer: Curated by HT Syndication.
